|Join Nairaland / LOGIN! / Trending / Recent / New|
Stats: 2,694,099 members, 6,349,504 topics. Date: Monday, 21 June 2021 at 02:08 PM
NAFDAC Approves Pfizer-Biotech COVID-19 Vaccine For Use In Nigeria / South Africa Sells Off Astrazeneca COVID Vaccine, Places Fresh Order From Pfizer / Israel Does An About Turn And Denies Covid-19 Vaccine Development (2) (3) (4)
|Biotech Stocks To Buy Beyond Covid Vaccine Development Before Report by angelance(m): 8:07am On Apr 13|
Rush to shares ahead of report
It seems that strategic investments have already begun to find their way home. It is clear that the time behind us that has been marked by the Coronavirus will also be reflected in the reporting flow of the medical research and pharmaceutical companies that have participated in the development of the vaccine are now highly valued for institutional investors, but also those in the statistics, which are seen as strategic investments for a quick return in the form of an increase in the value of these companies' shares.
However, there is still time to botanize around among the vaccine candidates who, purely financially, will do well with this past time in hand.
Here, however, some more in-depth analytical basis is required for everything to be pulled over one and the same comb, some examples of low-valued companies at this stage can still be mentioned as a relatively small chance of finding the big cut.
For example, we have put some hope in biotechnology companies such as Johnson & Johnson, Faron Pharmaceuticals Oy, Tonix Pharmaceuticals Holding Corp., and Oragenics Inc. to crack the code for the future Coronavirus vaccine and thereby contribute to strong growth for the coming years.
Start Trading and Receive up to $5000 in Trading Bonus. Visit the Publisher Site.
|Sections: politics (1) business autos (1) jobs (1) career education (1) romance computers phones travel sports fashion health |
religion celebs tv-movies music-radio literature webmasters programming techmarket
Nairaland - Copyright © 2005 - 2021 Oluwaseun Osewa. All rights reserved. See How To Advertise. 175